Author: Stefani Kim

Widex Moment Named CES 2023 Awards Honoree

Widex announced that it has been named a CES® 2023 Innovation Awards Honoree* for the company’s Widex Moment smartphone app (iOS and Android), which is a companion to Widex Moment and the new Widex Moment Sheer. All honorees and award winners were revealed during CES Unveiled New York on November 16 – ahead of CES 2023, taking place January 5-8, 2023 in Las Vegas, Nevada. 

Read More

Sensorion Announced Orphan Drug Designation for OTOF-GT

Sensorion (FR0012596468 – ALSEN) a clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat, and prevent within the field of hearing loss disorders, announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to OTOF-GT, Sensorion’s lead gene therapy program, intended for the treatment of otoferlin gene-mediated hearing loss. Sensorion is on track to file a Clinical Trial Application for OTOF-GT in the first half of 2023.

Read More

BIHIMA Announces Results of EuroTrak Research

One of the key headlines from the data, according to BIHIMA, is the number of hearing-impaired people using hearing instruments, which has risen to 53%. This is an increase of 12% over the last 10 years, demonstrating how the industry is reaching a greater number of people, however, there is still “much to do if we are to positively impact all those in need.”

Read More

GN Technologies Receive Three CES 2023 Awards

GN announced that it has been crowned CES 2023 Innovation Awards Honoree for three of its leading technologies. ReSound OMNIATM/Beltone Achieve, Custom made by ReSound/Beltone Imagine Custom rechargeable hearing aids, and Jabra Enhance Plus were each recognized by the CES Innovation Awards program.

Read More